AgraFlora Engages Seasoned Cannabis Executive to Drive Asset Commercialization and Shareholder Value Creation
27 Février 2020 - 9:05AM
AgraFlora Organics International Inc. (“AgraFlora” or the
“Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth
oriented and diversified international cannabis company, is pleased
to welcome John Fowler, founder of one of Canada’s top consumer
brands 7ACRES and former President and CEO of the Supreme Cannabis
Company, Inc. (TSX: FIRE) from 2014 to 2019. John Fowler is
the principal of Blaise Ventures Inc., a full-service consulting
firm that has been engaged by the Company to support the execution
of its strategic priorities to license, operationalize and solidify
a path to profitability for the Company’s key assets including:
Propagation Services Canada (“PSC”), Edibles & Infusions
Corporation (“Edibles & Infusions”), AAA Heidelberg Inc.
(“AAA”) and Farmako GmbH (“Farmako”). John and his team will
further assist AgraFlora’s management team in identifying,
evaluating and executing on accretive corporate opportunities
including potential acquisitions, dispositions or new revenue
channels in domestic or international markets.
“I entered 2020 looking for strong assets in the
cannabis industry where I felt that our team could contribute to
building strong and sustainable businesses, with a focus on
engaging with key consumer segments to drive profitability and
return on investment for shareholders,” said John Fowler, Principal
of Blaise Ventures. “I spent the latter part of 2019 meeting
with a wide range of cannabis companies throughout Canada, and was
particularly impressed by AgraFlora’s market opportunity, which is
further amplified by its key assets. Properly aligned, the
Company’s assets are well positioned in 2020 to transform from
development projects into customer-focused businesses that fill
unmet Canadian consumer demand in true commercial cannabis edible
production, high potency low cost cannabis flower, and craft
cannabis. In addition, I saw an important International
segment in the Farmako subsidiary which presents a great
opportunity to organically scale one of Germany’s leading medical
cannabis distributors into a leading distributor of medical
cannabis for all of Europe.”
To date, John Fowler and Blaise Ventures have
been focused on driving forward the licensing and commercialization
of PSC, a large-scale greenhouse facility located in Delta, BC, as
well as Edibles and Infusions, a highly automated cannabis edible
facility located in Winnipeg, MB. Supported by a team
equipped with deep industry experience and working directly with
Health Canada, the Company expects its facilities to be licensed,
operationalized and revenue generating before the end of
2020. Both PSC and Edibles & Infusions will focus first
on driving revenue through wholesale transactions, thus
accelerating revenue ramp-up while reducing associated selling and
marketing costs.
The Company will leverage John’s extensive
network of large and medium sized Canadian licensed producers,
brands and processors to further expedite revenue generation within
its wholesale model. Given the relative lack of large-scale,
professional gummy manufacturing and the growing opportunity for
well-priced, high-potency cannabis flower, Management believes that
both PSC and Edibles & Infusions are well positioned to emerge
as market disruptors when they enter revenue in Q4 2020.
“When I started in the cannabis industry, I did
not have the luxury of experienced partners given how nascent this
evolving space was at the time,” said John Fowler. “Furthermore, we
had to build our business in an environment of uncertainty with
respect to how the regulations and retail landscape would
develop. AgraFlora is in an enviable position as it
commercializes its assets at a time where most market dynamics are
known. Cannabis 1.0 and 2.0 products are in the market and we
have real consumer data to know what makes customers happy and what
drives their demand. We also have a clear understanding of
margin expectations within our B2B Channels, direct to consumer, as
well as medical and recreational channels.”
About AgraFlora Organics International Inc.
AgraFlora Organics International Inc. is a leading cannabis
company building shareholder value through the development of
revenue generating operating assets in the global cannabis
industry. AgraFlora is focused primarily on the Canadian
cannabis industry; the world’s most advanced and regulated legal
cannabis market. Flagship Canadian assets include: Edibles
& Infusions, a fully automated manufacturing facility in
Winnipeg, MB for white-label and consumer branded edible
production; Propagation Services Canada, a large-scale commercial
greenhouse in Delta, BC focused on reshaping the Canadian flower
market with high-potency, low cost cannabis flower, and AAA
Heidelberg, a craft focused cannabis producer in London, ON. In
addition, AgraFlora’s wholly owned subsidiary Farmako GmbH is
scaling towards its goal of being Europe’s leading distributor of
medical cannabis. Farmako currently has active distribution
operations in Germany and expects to commence active operations in
the United Kingdom in 2020. For more information please visit:
https://agraflora.com/.
ON BEHALF OF THE BOARD OF DIRECTORS
Brandon Boddy Chairman & CEOT: (604) 398-3147
For additional information: AgraFlora Organics
International Inc. Tim McNultyE: ir@agraflora.com T: (800)
783-6056 |
For French inquiries: Remy Scalabrini, Maricom Inc.E:
rs@maricom.ca T: (888) 585-MARI |
The CSE and Information Service Provider have
not reviewed and does not accept responsibility for the accuracy or
adequacy of this release.
Forward-looking Information Cautionary
Statement
Except for statements of historic fact, this
news release contains certain "forward-looking information" within
the meaning of applicable securities law. Forward-looking
information is frequently characterized by words such as "plan",
"expect", "project", "intend", "believe", "anticipate", "estimate"
and other similar words, or statements that certain events or
conditions "may" or "will" occur. Forward-looking statements are
based on the opinions and estimates at the date the statements are
made, and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those anticipated in the forward-looking statements
including, but not limited to delays or uncertainties with
regulatory approvals, including that of the CSE. There are
uncertainties inherent in forward-looking information, including
factors beyond the Company’s control. There are no assurances that
the business plans for AgraFlora Organics described in this news
release will come into effect on the terms or time frame described
herein. The Company undertakes no obligation to update
forward-looking information if circumstances or management's
estimates or opinions should change except as required by law. The
reader is cautioned not to place undue reliance on forward-looking
statements. Additional information identifying risks and
uncertainties that could affect financial results is contained in
the Company’s filings with Canadian securities regulators, which
are available at www.sedar.com.
Agra Ventures (CSE:AGRA)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Agra Ventures (CSE:AGRA)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025